Bacterial Vaginosis – A Serious Health Concern for Women


Bacterial Vaginosis pic
Bacterial Vaginosis

With over 30 years’ experience in pharmaceuticals, Taunia Markvicka serves as the chief commercial officer of Symbiomix Therapeutics in Newark, New Jersey. Taunia Markvicka has taken the lead in launching the company’s new product, Solosec.

Solosec has been approved for treatment of bacterial vaginosis (BV), a condition that affects some 21 million women ages 14-49. It is the most common gynecologic infection in that age group, and strikes women of color disproportionately.

The disease impairs the natural balance of lactobacilli (“good” bacteria) and anaerobic (“bad” bacteria) in the vagina, by producing too many of the anaerobic variety. Symptoms include a thin (gray, white, or green) discharge, a foul, fishy odor, itching, and burning while urinating.

BV has significant health consequences, such as an increased risk of sexually transmitted diseases (trichomoniasis, herpes, chlamydia, and gonorrhea), and untreated BV can lead to infertility. BV also increases the risk of premature birth. It can also lead to complications after gynecologic surgery. This diversity of risks, warrants greater education and research to improve health outcomes.

Risk factors for BV include multiple or new sex partners, same-sex relations among women, douching, and the absence of lactobacilli (“good”) bacteria.


The Work of Leaders – Exploring Key Processes

The Work of Leaders pic
The Work of Leaders

Taunia Markvicka, PharmD, MBA, is a well established pharmaceutical professional who serves Symbiomix Therapeutics, LLC, as chief commercial officer. Her responsibilities have included overseeing Solosec commercialization efforts, including market analysis, investor relations, product life cycle, transition leader. As organizations go through change, it is valuable to draw on your experience, values, and continuous learning based on the current situation. Taunia Markvicka enjoys growing her career knowledge and reading in her free time and recently completed The Work of Leaders: How Vision, Alignment, and Execution Will Change the Way You Lead.

The book brings focus to the essential skills of leaders, with the first involving the ability to envision a future state of being. Presenting inherent challenges, this vision can be turned into reality only through the coordinated efforts of team members.

Aligning efforts centers on ensuring that each group member is both aware of the overall vision and willing to invest in the idea through an active commitment to making it happen. This typically involves getting key team members on board as part of the overall strategic orientation and giving them proper incentive as well as recognition for their work.

The third quality detailed in The Work of Leaders involves championing execution. At some point in any extended effort energy and commitment flags. The effective leader has the ability to bring together the particular motivational elements necessary to see a project through to successful completion.

Supported by comprehensive research, the book reflects the results of large-scale surveys and studies, and seeks to demystify the leadership role in ways that relate to how organizations really operate. Just as with personal development, a core insight is that developing as a leader requires knowing where and when to direct energy that, by definition, is finite. The book has several practical guides to support vision, alignment, execution that every leader can implement in their own environment.